Medtech's Unfinished Business For Congress In 2018: What's Ahead
US Congress successfully pushed through a user-fee bill in 2017 to help smooth the regulatory path at FDA for medical devices and other products, but other efforts, including several industry priorities, remain undone. On top on the list, of course, is the effort to repeal the device excise tax. But legislation is also on the table to address diagnostics regulation, telehealth reimbursement, and medtech cybersecurity vulnerability, among other issues. Here is a look at the medtech landscape in Congress in 2018.
You may also be interested in...
US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
With most of the Nov. 6 election tally completed, it’s clear there will be many new faces for the device industry to engage with in the halls of Congress, but the sector still appears to have a significant group of supporters on Capitol Hill. Also, several medtech-relevant measures were on the ballot.
Message To US Congress: Know What Cybersecurity Tools You Have, Share What You Know, Untie Our Hands
Responding to US lawmakers on how to tackle cybersecurity threats to medical devices and the health-care system, device firms, hospitals, provider groups and other stakeholders listed recommendations on creating inventories, sharing information and amending laws.
Medtech Groups To Blitz Congress Before Expected House Device Tax Vote
After Minnesota Congressman Erik Paulsen seemed to confirm plans for a floor vote on the medical device excise tax repeal before August, medical device lobby groups say they are rallying to get the deal done before it gets pushed off the agenda by the upcoming US Supreme Court nomination process.